This list contains only the countries for which job offers have been published in the selected language (e.g., in the French version, only job offers written in French are displayed, and in the English version, only those in English).
The University of Kansas Health System, Kansas Cancer Center (an NCI-Designated Comprehensive Cancer Center), is seeking a Clinician Scientist in immune-effector cell therapy to join the Division of Hematologic Malignancies & Cellular Therapeutics. We are the region's largest BMT and Cellular Immunotherapy program in Kansas. The candidate will have access to world- class resources including a new cancer center under construction. This is an opportunity to shape the future of cancer immunotherapy by driving translational research at the interface of discovery, preclinical development, and early-phase clinical trials. The successful candidate will advance next-generation approaches, including CAR-T/NK therapies, engineered macrophages/monocytes, and combination immunotherapies for hematologic and solid tumors.
Job Responsibility:
Establish an innovative and externally funded research program
Design, lead and execute translational studies in immune-effector cell therapy (e.g., CAR constructs, BiTEs, “armored” cells, logic-gated circuits) that enable generation of patentable IEC intellectual property
Recruit additional faculty to expand research within the IEC program
Design and oversee in vitro functional assays (killing, cytokine profiling, spectral flow, scRNA-seq/CITE-seq) and in vivo preclinical efficacy/toxicity models
Collaborate with KUCC’s cGMP manufacturing, the Institute for Advancing Medical Innovation (IAMI), Clinical Trials Office, Pathology, and Biostatistics to advance First-in-Human, enabling investigational new drug submissions to FDA and lead/participate in IEC early phase clinical trials
Contribute to the preparation of regulatory documentation (IACUC/IRB, Biosafety, IND/IDE modules), study protocols, and clinical correlative science plans
Mentor trainees (graduate students, residents, postdocs and fellows) as well as junior faculty and coordinate cross-functional project teams
Disseminate results via manuscripts, conference abstracts, and grant applications (NIH, LLS, foundations)
Requirements:
MD or PhD in Immunology, Hematology/Oncology
Cancer Biology, Bioengineering, or related field
2–5 years post-degree research experience in immune-effector cell therapy or closely related area
Hands-on expertise in cell engineering (viral/non-viral delivery
CRISPR or equivalent), primary T/NK cell culture, and functional immunology assays
Previous extramural funding: i.e., K award, R21, DOD
Demonstrated track record of impactful publications and team-based science